About

Hypertension is the most common modifiable risk factor for cardiovascular disease and death, and lowering blood pressure with antihypertensive drugs reduces target organ damage and prevents cardiovascular disease outcomes.

Most hypertensive patients will need a combination of antihypertensive agents to achieve the therapeutic goals. Recent guidelines recommend initiating treatment with two drugs in those patients with a systolic blood pressure >20 mmHg and/or a diastolic blood pressure >10 mmHg above the goals, and in those patients with high cardiovascular risk. In addition, approximately 25% of patients will require three antihypertensive agents to achieve the therapeutic targets.

Articles

Early Management of Hypertension

Published:

13 March 2019

Citation:

US Cardiology Review 2019;13(1):58–60

Hypertension and Stroke: Update on Treatment

Published:

11 July 2019

Citation:

European Cardiology Review 2019;14(2):111–5

Baroreflex Activation Therapy for Resistant Hypertension and Heart Failure

Published:

07 February 2020

Citation:

US Cardiology Review 2019;13(2):83–7.

Characteristics of Lipid Profile of LPL Deficiency in Japan – Comparison with Non-LPL Deficiency

Citation:

European Cardiology Review 2018;13(2):132.